AVITA Medical, Inc. financial data

Symbol
RCEL on Nasdaq, AVHHL on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
28159 Avenue Stanford, Suite 220, Valencia, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Avita Therapeutics, Inc. (to 12/10/2020), Avita Medical, Ltd. (to 6/30/2020)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 584 % -13.2%
Quick Ratio 45.9 % +77.5%
Debt-to-equity 219 % +954%
Return On Equity -195 % -325%
Return On Assets -60.7 % -61.4%
Operating Margin -98.1 % -22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.2M shares +2.61%
Common Stock, Shares, Outstanding 26.2M shares +2.61%
Entity Public Float 432M USD +268%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26M shares +2.29%
Weighted Average Number of Shares Outstanding, Diluted 26M shares +2.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 60M USD +32.2%
Cost of Revenue 8.61M USD +17.4%
Research and Development Expense 22.3M USD +27.8%
Selling and Marketing Expense 54.3M USD +62.5%
General and Administrative Expense 33.8M USD +30.6%
Operating Income (Loss) -58.9M USD -62.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -57.3M USD -70.5%
Income Tax Expense (Benefit) 47K USD -39.7%
Net Income (Loss) Attributable to Parent -57.3M USD -70.2%
Earnings Per Share, Basic 0.57 USD/shares -82.4%
Earnings Per Share, Diluted 0.57 USD/shares -82.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.6M USD -63.3%
Marketable Securities, Current 25.8M USD +178%
Accounts Receivable, after Allowance for Credit Loss, Current 10.3M USD +75.1%
Inventory, Net 6.23M USD +42.3%
Other Assets, Current 8K USD -98.5%
Assets, Current 63.9M USD -13.5%
Property, Plant and Equipment, Net 9.15M USD +391%
Operating Lease, Right-of-Use Asset 3.78M USD +45%
Intangible Assets, Net (Excluding Goodwill) 590K USD +28.5%
Other Assets, Noncurrent 546K USD +131%
Assets 81.1M USD +0.05%
Liabilities, Current 17.1M USD +44.8%
Contract with Customer, Liability, Noncurrent 332K USD -9.04%
Operating Lease, Liability, Noncurrent 3.08M USD +66.9%
Other Liabilities, Noncurrent 715K USD +42.1%
Liabilities 68.6M USD +294%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.07M USD -126%
Retained Earnings (Accumulated Deficit) -348M USD -19.7%
Stockholders' Equity Attributable to Parent 12.2M USD -80.6%
Liabilities and Equity 81.1M USD +0.05%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.9M USD -130%
Net Cash Provided by (Used in) Financing Activities 631K USD +269%
Net Cash Provided by (Used in) Investing Activities 15.1M USD -19.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.2M shares +2.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.17M USD -152%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.6M USD -63.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36K USD
Deferred Tax Assets, Valuation Allowance 63.3M USD +12%
Deferred Tax Assets, Gross 63.9M USD +12.7%
Operating Lease, Liability 4.1M USD +141%
Depreciation 839K USD +55.1%
Payments to Acquire Property, Plant, and Equipment 1.15M USD +304%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -67.4M USD -104%
Lessee, Operating Lease, Liability, to be Paid 5.17M USD +172%
Operating Lease, Liability, Current 820K USD +25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13M USD +155%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD +57.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +25.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.07M USD +433%
Lessee, Operating Lease, Liability, to be Paid, Year Three 773K USD +105%
Deferred Tax Assets, Operating Loss Carryforwards 50.4M USD +4.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 658K USD
Operating Lease, Payments 991K USD +21.4%
Additional Paid in Capital 364M USD +4.78%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 66K USD +94.1%
Depreciation, Depletion and Amortization 203K USD +50.4%
Deferred Tax Assets, Net of Valuation Allowance 624K USD +160%
Share-based Payment Arrangement, Expense 12.9M USD +73.2%
Interest Expense 5.18M USD +13490%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%